STRUCTURE-ACTIVITY-RELATIONSHIPS OF AN ENDOTHELIN ETA RECEPTOR ANTAGONIST, 50-235, AND ITS DERIVATIVES

被引：17
|
作者：
MIHARA, SI [1 ]
SAKURAI, K [1 ]
NAKAMURA, M [1 ]
KONOIKE, T [1 ]
FUJIMOTO, M [1 ]
机构：
[1] SHIONOGI & CO LTD,SHIONOGI RES LAB,5-12-4 SAGISU,FUKUSHIMA KU,OSAKA 553,JAPAN
来源：
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION | 1993年 / 247卷 / 02期
关键词：
27-O-CAFFEOYL MYRICERONE (50-235); STRUCTURE-ACTIVITY RELATIONSHIP; ENDOTHELIN RECEPTOR ANTAGONIST; I-125]ENDOTHELIN-1 BINDING; CYTOSOLIC FREE CA(2+);
D O I：
10.1016/0922-4106(93)90081-J
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
27-O-Caffeoyl myricerone (50-235) is a nonpeptide endothelin receptor antagonist which is highly selective for the endothelin ET(A) receptor subtype. In order to determine which functional groups in 50-235 are essential for its activity, we examined the potencies of 50-235 and its derivatives to inhibit [I-125]endothelin-1 binding and endothelin-1-induced increase in the cytosolic Ca2+ concentration in rat aortic smooth muscle A7r5 cells. The results suggest that the 3-keto, 17-carboxyl and 27-caffeoyl groups in 50-235 are important for ET(A) receptor blocking activity. Modifications of the catechol ring of the 27-caffeoyl group influenced the affinity and the functional antagonist activity, but the effects were not parallel.
引用
收藏
页码：219 / 221
页数：3
相关论文
共 50 条
  • [21] REANALYSIS OF THE STRUCTURE-ACTIVITY-RELATIONSHIPS OF SULFONAMIDE DERIVATIVES
    SILIPO, C
    VITTORIA, A
    FARMACO-EDIZIONE SCIENTIFICA, 1979, 34 (10): : 858 - 868
  • [22] STRUCTURE-ACTIVITY-RELATIONSHIPS AMONG DDT DERIVATIVES
    COATS, JR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1981, 182 (AUG): : 14 - PEST
  • [23] STRUCTURE-ACTIVITY-RELATIONSHIPS FOR ANTICHOLINERGIC MORPHOLINIUM DERIVATIVES
    TINLAND, B
    FARMACO-EDIZIONE SCIENTIFICA, 1975, 30 (11): : 935 - 936
  • [24] STRUCTURE-ACTIVITY-RELATIONSHIPS OF NITRONAPHTHOBENZOFURANS DERIVATIVES FOR GENOTOXICITY
    MOENS, W
    ARANY, J
    HENDRICKX, B
    LAKHANISKY, T
    ROS, Y
    VLEMINCKX, C
    ROJER, R
    BUISSON, JP
    MUTATION RESEARCH, 1987, 181 (02): : 338 - 339
  • [25] STRUCTURE-ACTIVITY-RELATIONSHIPS OF A SERIES OF POTENT PEPTIDIC ENDOTHELIN ANTAGONISTS
    DEPUE, PL
    DOHERTY, AM
    CODY, WL
    HE, JX
    WAITE, LA
    DUNBAR, JB
    HALEEN, SJ
    LADOUCEUR, DM
    HILL, KE
    FLYNN, MA
    REYNOLDS, EE
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 204 : 36 - MEDI
  • [26] STRUCTURE-ACTIVITY-RELATIONSHIPS OF A NEUROHYPOPHYSEAL GABA RECEPTOR
    MATHISON, RD
    DREIFUSS, JJ
    BRAIN RESEARCH, 1980, 187 (02) : 476 - 480
  • [27] MONAMIDOCIN, A NOVEL FIBRINOGEN RECEPTOR ANTAGONIST .2. BIOLOGICAL-ACTIVITY AND STRUCTURE-ACTIVITY-RELATIONSHIPS
    KAMIYAMA, T
    SATOH, T
    UMINO, T
    KATOH, H
    UEMURA, F
    NAKAMURA, Y
    YOKOSE, K
    JOURNAL OF ANTIBIOTICS, 1995, 48 (11): : 1226 - 1233
  • [28] STRUCTURE-ACTIVITY-RELATIONSHIPS IN THE SERIES OF MUSCARINIC ANTAGONISTS - 4 MODES OF ANTAGONIST-RECEPTOR BINDING
    TROPSHA, AE
    NIZHNY, SV
    YAGUZHINSKY, LS
    BIOORGANICHESKAYA KHIMIYA, 1985, 11 (10): : 1402 - 1416
  • [29] STRUCTURE-ACTIVITY-RELATIONSHIPS OF NOVEL SUBSTITUTED CHALCONE DERIVATIVES
    GRILLIER, I
    BOURGUET, W
    SABLONNIERE, B
    MANECHEZ, D
    CHEN, JY
    FORMSTECHER, P
    DAUTREVAUX, M
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1993, 100 (02) : 215 - 215
  • [30] STRUCTURE-ACTIVITY-RELATIONSHIPS OF PHENCYCLIDINE DERIVATIVES IN RAT CEREBELLUM
    PANG, K
    JOHNSON, SW
    MAAYANI, S
    FREEDMAN, R
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1986, 24 (01) : 127 - 134
12345